| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/23/2008 | CN101108220A Medicine for treating hepatitis |
| 01/23/2008 | CN101108219A Method of preparing traditional Chinese medicine formulated product for treating gastroenteritis |
| 01/23/2008 | CN101108213A Multiple-effect body-building medicine liqueur |
| 01/23/2008 | CN101108204A Application of flax root total flavone in preparing medicament for preventing and/or treating hepatitis |
| 01/23/2008 | CN101108188A Novel long circulation alprostadil liposome drug feeding system for injection and method of preparing the same |
| 01/23/2008 | CN101108179A Legalon pharmaceutical preparation and method for preparing the same |
| 01/23/2008 | CN101108176A Treating smooth muscle hyperactivity with (R)-oxybutynin and (R)- desethyloxybutynin |
| 01/23/2008 | CN101108173A Application of p-hydroxybenzene ethanone and its derivant in preparation of agentia treating gallstone disease |
| 01/23/2008 | CN101108172A Oral sticking tablet and method of preparing the same |
| 01/23/2008 | CN101108017A Root of balloonflower regulating the middle warmer beverage |
| 01/23/2008 | CN101108001A Food with healthcare function |
| 01/23/2008 | CN101108000A Addition-application method of functional properties fat planting food mixture |
| 01/23/2008 | CN101107995A Traditional Chinese medicine health care beverage bag |
| 01/23/2008 | CN100363479C Method for preparing micrometer ginseng, pilose antler, pearl and pollen pini yang strengthening wine |
| 01/23/2008 | CN100363363C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/23/2008 | CN100363359C Motilide compounds |
| 01/23/2008 | CN100363053C Intracellular isoform of the interleukin-1 receptor antagonist |
| 01/23/2008 | CN100363046C Prepn for treating fatty liver and alcoholic liver and its prepn process |
| 01/23/2008 | CN100363045C Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate for treating hepatitis accessorily |
| 01/23/2008 | CN100363042C Composition comprising biphenyldicarboxylate |
| 01/23/2008 | CN100363041C Traditional Chinese medicine and western medicine cooperative compositions comprising biphenyldicarboxylate |
| 01/23/2008 | CN100363034C Chinese medicinal composition for treating ascites due to cirrhosis |
| 01/23/2008 | CN100363032C Eggplant root extract and its preparing method and use |
| 01/23/2008 | CN100363028C Capsule for treating stomach-ache and preparing method |
| 01/23/2008 | CN100363027C Liver-care composition and its prepn. method |
| 01/23/2008 | CN100363025C Method for preparing aconturm fischeri mankshood |
| 01/23/2008 | CN100363020C Throat powder formula for treating throat and oral diseases |
| 01/23/2008 | CN100363012C Cordyceps sinensis polysaccharide emulsion and preparing method thereof |
| 01/23/2008 | CN100362990C Fibrauretine-amino acid fluid for transfusion and its production process |
| 01/23/2008 | CN100362984C Prepn. method of matrine magnetic micro-ball |
| 01/23/2008 | CN100362949C Healthy product for gastrointestinal tract |
| 01/23/2008 | CN100362930C Method for preparing soymilk pellets contg. micron additives for tonifying spleen and helping digestion |
| 01/22/2008 | US7320999 Immunosuppressants, organ transplantation, autoimmune diseases, rheumatic diseases |
| 01/22/2008 | US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320977 Substituted 2-phenyl-3(2h)-pyridazinones |
| 01/22/2008 | US7320973 5,11-Dihydrodiaryl[b,e][1,4,]oxazepine derivatives for gastrointestinal disorder treatment; irritable bowel syndrome |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320875 Screening for neutralizing hepatitis C virus antibodies in a blood sample utilizing an HCV E2 protein and a protein from a human or chimpanzee cell that has a molecular weight of 24 kd that binds to the E2 protein of HCV; comparing the amount of bound proteins to that in the absence of HCV antibodies |
| 01/22/2008 | US7320872 Genetically engineered nervous system cells for use in the treatment of alzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, trauma, brain, muscle, cardiovascular, vision , liver, kidney and pancreas disorders |
| 01/22/2008 | US7320803 Free from water of crystallization; use in foods, animal feeds, or in food supplements |
| 01/22/2008 | CA2490638C Combination therapy wherein a serotonin reuptake inhibitor is used |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/17/2008 | WO2008008637A2 Antioxidant combinations for use in ruminant feed rations having a fat source |
| 01/17/2008 | WO2008008544A2 Equine whole food supplements |
| 01/17/2008 | WO2008008359A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 01/17/2008 | WO2008007728A1 Oral preparation in the form enclosed in lipid membrane structure, and fatigue-ameliorating agent comprising coenzyme a as active ingredient |
| 01/17/2008 | WO2008007691A1 Salt of morpholine compound |
| 01/17/2008 | WO2008007063A2 Anti-obesity product and it's method of preparation |
| 01/17/2008 | WO2008006828A1 Zilpaterol enantiomer compositions and methods of making and using such compositions |
| 01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | WO2008006168A1 Treatment of excessive neovascularization |
| 01/17/2008 | WO2007134086A3 Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis |
| 01/17/2008 | WO2007117577A3 High affinity human antibodies to human il-18 receptor |
| 01/17/2008 | WO2007114922A3 Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor |
| 01/17/2008 | WO2007113202A8 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists |
| 01/17/2008 | WO2004106938A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 01/17/2008 | WO2004106935A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103) |
| 01/17/2008 | US20080015242 Use of N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydroxyethyl]phenyl]methanesulfonamide or salt for treating diabetes, obesity, hyperlipidemia and urinary incontinence; drug interaction side effect reduction |
| 01/17/2008 | US20080015239 For glaucoma or ocular hypertension, irritable bowel disease, and maintenance of colonic mucous |
| 01/17/2008 | US20080015227 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme |
| 01/17/2008 | US20080015222 New Heterocyclic Amides |
| 01/17/2008 | US20080015218 Antioxidant combinations for use in ruminant feed rations having a fat source |
| 01/17/2008 | US20080015217 Antioxidant combinations for use in ruminant feed rations |
| 01/17/2008 | US20080015214 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 01/17/2008 | US20080015211 Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | US20080015200 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015177 S1P receptor modulating compounds and use thereof |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015166 Eicosapentaenoic acid, docosahexaenoic acid, arachidonic acid and at least two distinct oligosaccharides; reduce epithelial paracellular permeability; diarrhea |
| 01/17/2008 | US20080015157 Novel Water-Soluble Prodrugs |
| 01/17/2008 | US20080015146 e.g. 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 01/17/2008 | US20080014292 Composition for treating and/or preventing periodontal disease |
| 01/17/2008 | US20080014286 Metal-containing materials |
| 01/17/2008 | US20080014283 Treatment methodologies for preventing reflux induced adenocarcinoma of the esophagus |
| 01/17/2008 | US20080014278 Metal-containing formulations and methods of use |
| 01/17/2008 | US20080014273 Equine whole food supplements |
| 01/17/2008 | US20080014270 Methods for improved lipid metabolism and basal metabolic rate with lactoferrin |
| 01/17/2008 | US20080014262 Rapidly disintegrating tablet containing polyvinyl alcohol |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014247 Metal-containing formulations and methods of use |
| 01/17/2008 | US20080014228 Solid form |
| 01/17/2008 | US20080014215 Animal Bioreactors |
| 01/17/2008 | US20080014197 Neutralizing human anti-igfr antibody |
| 01/17/2008 | US20080014185 Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth |
| 01/17/2008 | CA2659590A1 Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | CA2657308A1 Treatment of excessive neovascularization |
| 01/16/2008 | EP1878743A2 Urotensin-II agonists and antagonists |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/16/2008 | EP1878436A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 01/16/2008 | EP1878434A1 Use of extracts from pelargonium sidoides and/or pelargonium reniforms for manufacturing preparations and preparations containing these extracts |
| 01/16/2008 | EP1877410A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity |